About Nuvalent, Inc. 
Nuvalent, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 64 Schemes (34.62%)
Foreign Institutions
Held by 110 Foreign Institutions (9.92%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-100 Million
Pharmaceuticals & Biotechnology
USD 5,756 Million ()
NA (Loss Making)
NA
0.00%
-1.07
-33.83%
6.13






